By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actavis 

Morris Corporate Center III
400 Interpace Parkway
Parippany  New Jersey  07054  U.S.A.
Phone: 1-862-261-7000 Fax: n/a


SEARCH JOBS

Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland.

Actavis is the world’s third-largest generics prescription drug manufacturer, with more than 750 products marketed globally through operations in more than 60 countries. Actavis’ global branded pharmaceutical business develops and markets products principally in Urology and Women’s Health, and is committed to developing and marketing biosimilars products in Women’s Health, Oncology and other therapeutic categories. In addition, Actavis is the fourth-largest U.S. generic pharmaceutical product distributor through its Anda, Inc. business, and also develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.

"Twice As" Video

"Our Winning Way" Video


Key Statistics


Email: actavis@actavis.com
Ownership: Public

Web Site: Actavis
Employees:
Symbol: ACT
 



Industry
Pharmaceutical






Company News
Actavis (ACT) To Host First Quarter 2015 Earnings Conference Call And Webcast 4/16/2015 8:05:50 AM
With Ackman's Blessing, Actavis (ACT) Chairman Joins Zoetis (ZTS) Board 4/14/2015 7:05:11 AM
Actavis (ACT) Owes No Apology for Seeking New Alzheimer's Drug Profits, Says Lawyer 4/14/2015 6:47:43 AM
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-releasing intrauterine system) 52 Mg To Prevent Pregnancy For Up To Three Years 4/14/2015 6:40:11 AM
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Three Years 4/13/2015 7:39:16 AM
Actavis (ACT) Confirms Generic Letairis Patent Challenge 4/6/2015 8:17:37 AM
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015 11:46:56 AM
Actavis (ACT) Slashing More Than 400 Jobs in New York 3/18/2015 7:04:28 AM
Actavis (ACT) Announces Michael R. Gallagher And Peter J. Mcdonnell To Join Board Of Directors 3/17/2015 11:01:18 AM
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015 9:45:13 AM
12345678910...
//-->